Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens Journal:European Journal of Haematology | 2015 | 55 | ||
2016 | 107 | |||
2019 | 81 |